Tradestie Institutional Equity Comparison Engine

DCM vs NMR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

NMR Overall Edge

NMR Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Nomura Holdings, Inc (NMR) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, DCM trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus NMR at 11.4x Forward P/E and 25.1% operating margin (+17.9% YoY). In options structure, DCM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against NMR sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner NMR
DCM N/M vs NMR 11.4x Fwd P/E
Growth & Margin Winner NMR
Op Margin N/A vs 25.1% ยท YoY N/A vs +17.9%
Momentum & Technical Winner NMR
1Y -34.4% vs +21.8% ยท 52W Pos 0% vs 40%
Options & Structure Winner NMR
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (<1st %ile IV)
DCM US Equity
DCM
Institutional Equity
$2.82
-6.62% 1D
Market Cap N/A
1M Return -26.75%
1Y Return -34.42%
Forward P/E N/M
Unified AI Score
48.8 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0
NMR NYSE
Nomura Holdings, Inc
Security Brokers, Dealers & Flotation Companies
$8.51
-5.86% 1D
Market Cap $26.4B
1M Return -5.86%
1Y Return +21.75%
Forward P/E 11.4x
Unified AI Score
35.0 / 100 SELL
Tech 13.0 Fund 35.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: DCM -34.42% NMR +21.75% Spread: +27.73 pp (NMR Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
DCM TTM Op. Margin: N/A NMR TTM Op. Margin: 25.1%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DCM vs NMR. Trailing 12-month operating profitability (DCM N/A vs NMR 25.1%) and valuation multiples (DCM N/M vs NMR 11.4x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: DCM (1) vs NMR (9)
Institutional Metric DCM NMR Criterion Row Winner
Market Capitalization Scale N/A $26.4B Larger Scale NMR
Trailing P/E Ratio Valuation N/M 10.4x Lower Multiple NMR
Forward P/E Ratio Valuation N/M 11.4x Lower Multiple NMR
Revenue Growth (YoY) Growth N/A +17.9% Higher Growth NMR
Operating Margin (TTM) Profitability N/A 25.1% Higher Margin NMR
Net Profit Margin Profitability N/A 17.1% Higher Margin NMR
Return on Equity (ROE) Capital Efficiency N/A 11.5% Higher ROE NMR
52-Week Range Position Momentum 0% ($3โ€“$5) 40% ($7โ€“$11) Stronger Trend NMR
Beta / 30D Volatility Risk Regime N/A 1.04ฮฒ ยท 34% Vol Lower Realized Risk NMR
Unified Institutional Score Composite Signal 48.8 / 100 (HOLD) 35.0 / 100 (SELL) Higher Composite DCM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full DCM vs NMR Buy Guide
DCM UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live DCM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
NMR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live NMR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither DCM nor NMR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.